Taken together, although CD4+ and CD8+ T cells were shown to be able to recognize CLL tumor cells, functional modulation by the tumor clone leads to inhibition of T-cell-mediated immune responses and inadequate tumor control. This evidence concerns the gene CD8A and neoplasm.